Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.86 USD
−189.30 M USD
278.30 M USD
49.56 M
About Cardlytics, Inc. Common Stock
Sector
Industry
CEO
Amit Gupta
Website
Headquarters
Atlanta
Founded
2008
FIGI
BBG00225ZDD0
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
CDLX will have to fill the gap in its way down. SELL Now.CDLX will have to fill the gap below. The "news" for the day trade are over, now reality should kick in, first stop is at 13.3, then it'll gradually fall back to 8. The company is losing money and it will continue to lose money, Estimated Q1 2024 EPS is Very Negative, no matter what the pumpers say,
CDLX to Fall from here, see Estimated Q1 EPS: VERY NEGATIVEToo much enthusiasm for a losing money company, good trade on the news maybe, but destine to fall back to 5$, Just look at the super negative earnings estimate for Q1, very negative from here, good luck in the way back down, ALL GAPS MUST BE FILLED.
CDLX Market AnalysisCDLX Market Analysis about market maker movesCDLX Market Analysis about market maker movesCDLX Market Analysis about market maker movesCDLX Market Analysis about market maker movesCDLX Market Analysis about market maker movesCDLX Market Analysis about market maker movesCDLX Market Analysis about mar
Every sign points to 40On a shocking earnings beat it isn't surprising to see a price increase as drastic as was seen Tuesday morning. Looking at return on investment, earnings in general, and analyzing the company I come to find that with a low margin of operation it has managed to build a bit of a bubble since it's IPO.
021. PIGGISH PLAY - Short Cardlytics (CDLX)Cardlytics (noun) - the study of companies that create a purposefully enigmatic and cool-ish-sounding name to attract investors without the need for a profitable business model.
Cardlytics (noun) - the best possible company to short on Monday afternoon before it announces its quarterly numbers afte
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
CDLX5265235
Cardlytics, Inc. 1.0% 15-SEP-2025Yield to maturity
8.85%
Maturity date
Sep 15, 2025
CDLX6046219
Cardlytics, Inc. 4.25% 01-APR-2029Yield to maturity
—
Maturity date
Apr 1, 2029
See all CDLX bonds
Related stocks
Frequently Asked Questions
The current price of CDLX is 1.45 USD — it has increased by 9.93% in the past 24 hours. Watch Cardlytics, Inc. Common Stock stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cardlytics, Inc. Common Stock stocks are traded under the ticker CDLX.
CDLX stock has risen by 1.31% compared to the previous week, the month change is a −29.22% fall, over the last year Cardlytics, Inc. Common Stock has showed a −88.73% decrease.
We've gathered analysts' opinions on Cardlytics, Inc. Common Stock future price: according to them, CDLX price has a max estimate of 5.00 USD and a min estimate of 2.50 USD. Watch CDLX chart and read a more detailed Cardlytics, Inc. Common Stock stock forecast: see what analysts think of Cardlytics, Inc. Common Stock and suggest that you do with its stocks.
CDLX reached its all-time high on Feb 16, 2021 with the price of 161.47 USD, and its all-time low was 1.22 USD and was reached on Apr 8, 2025. View more price dynamics on CDLX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CDLX stock is 9.38% volatile and has beta coefficient of 2.26. Track Cardlytics, Inc. Common Stock stock price on the chart and check out the list of the most volatile stocks — is Cardlytics, Inc. Common Stock there?
Today Cardlytics, Inc. Common Stock has the market capitalization of 80.87 M, it has decreased by −9.78% over the last week.
Yes, you can track Cardlytics, Inc. Common Stock financials in yearly and quarterly reports right on TradingView.
Cardlytics, Inc. Common Stock is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
CDLX earnings for the last quarter are −0.31 USD per share, whereas the estimation was −0.47 USD resulting in a 34.04% surprise. The estimated earnings for the next quarter are −0.48 USD per share. See more details about Cardlytics, Inc. Common Stock earnings.
Cardlytics, Inc. Common Stock revenue for the last quarter amounts to 74.00 M USD, despite the estimated figure of 63.63 M USD. In the next quarter, revenue is expected to reach 58.07 M USD.
CDLX net income for the last quarter is −15.59 M USD, while the quarter before that showed −145.18 M USD of net income which accounts for 89.26% change. Track more Cardlytics, Inc. Common Stock financial stats to get the full picture.
No, CDLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 16, 2025, the company has 454 employees. See our rating of the largest employees — is Cardlytics, Inc. Common Stock on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cardlytics, Inc. Common Stock EBITDA is −35.66 M USD, and current EBITDA margin is −12.81%. See more stats in Cardlytics, Inc. Common Stock financial statements.
Like other stocks, CDLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cardlytics, Inc. Common Stock stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cardlytics, Inc. Common Stock technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cardlytics, Inc. Common Stock stock shows the sell signal. See more of Cardlytics, Inc. Common Stock technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.